Subcutaneous and sublingual immunotherapy in adults and ...

Work Health and Safety Act 2011. Medication, Poisons and therapeutic goods act (2008) Back to Table of Contents. References Andrews, S., & Holden, R. (2012). Characteristics and management of immune-related adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Management and Research, 4, 299-307. ................
................